Background: Breast cancer (BC) remains a significant health issue globally and most common cause of mortality in women. Enhancing our understanding on biomarkers may greatly improve both diagnostic and therapeutic approaches to this disease.
Methods: We retrospectively assessed tumor samples from 228 BC cases and 51 normal samples, alongside relevant clinical data.